NCT01039558 is a NA clinical trial of ecabet sodium in Gastroesophageal Reflux Disease, sponsored by Seoul National University Hospital.

Who is sponsoring NCT01039558?

NCT01039558 is sponsored by Seoul National University Hospital.

What drugs are being tested in NCT01039558?

Interventions in NCT01039558: ecabet sodium, lansoprazole, placebo.

What condition does NCT01039558 study?

NCT01039558 studies Gastroesophageal Reflux Disease.

Is NCT01039558 still recruiting?

NCT01039558 is currently completed. Last updated 27 July 2011.

Last reviewed 2011-07-27 · How we verify

NCT01039558

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Randomized Controlled Trial to Evaluate the Effect of Lansoprazole in Combination With Ecabet Sodium for Gastroesophageal Reflux Disease

Completed NA Last updated 27 July 2011

What this trial tests

NA trial testing ecabet sodium in Gastroesophageal Reflux Disease in 30 participants. Completed in 1 March 2011.

Timeline

1 December 2009

Primary endpoint
1 March 2011

1 March 2011

Quick facts

Lead sponsor	Seoul National University Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	30
Start date	1 December 2009
Primary completion	1 March 2011
Estimated completion	1 March 2011
Sites	1 location across South Korea

Drugs / interventions tested

ecabet sodium — full drug profile →
lansoprazole (lansoprazole) — full drug profile →
placebo

Conditions studied

Gastroesophageal Reflux Disease — all drugs for Gastroesophageal Reflux Disease →

Sponsor

Seoul National University Hospital

Who can join

Adults 19 to 75, any sex, with Gastroesophageal Reflux Disease. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

We will compare the summations of symptoms score and calculate the response rate
Time frame: after 4 weeks and 8 weeks

Sponsor's own description

We will estimate the responses of lansoprazole and ecabet sodium combination therapy and compare with lansoprazole and placebo therapy in patients who need additional therapy after standard proton pump inhibitor treatment for 4week or more in recurrent gastroesophageal reflux disease.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Gastroesophageal Reflux Disease

Currently open trials in the same condition.

NCT06783751 — Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG) · NA · recruiting
NCT06348420 — Anti-reflux Mucosal Valvuloplasty Versus PPIs for GERD Treatment · NA · recruiting
NCT06991348 — Clinical Trial for the Comparative Evaluation of Acid Suppression and Symptom Management of Gastroesophageal Reflux Dise · Phase 4 · recruiting
NCT06732661 — Preserving the Pre-cardial Fat Pad During Sleeve Gastrectomy on Postoperative Gastroesophageal Reflux · NA · active not recruiting
NCT05514769 — Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty Versus Esophagogastric Anastomosis for Gastric Cancer · NA · recruiting

Other Seoul National University Hospital trials

Trials by the same sponsor.

NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01039558 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
Last refreshed: 27 July 2011

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01039558.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing